New light shed on who benefits most from weight-loss jabs
People who carry variations in two genes linked to appetite and digestion can lose more weight when taking drugs to treat obesity, research suggests.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"The study found a genetic variant associated with weight loss, which was also associated with nausea."
— Professor Ruth Loos , Academic
"If you carry the variant, you will lose more weight."
— Professor Ruth Loos , Academic
"Genetics is only one part of a much more complex picture."
— Dr Marie Spreckley , Academic
Key People
Tags
All Coverage
People who carry variations in two genes linked to appetite and digestion can lose more weight when taking drugs to treat obesity, research suggests.
Similar Stories
Related coverage based on topic and tags
New weight-loss pill approved for use in UK
Foundayo is made by Eli Lilly, the drug firm behind the Mounjaro jab.
August 10, 2026 at 03:25 PMWeekly type 2 diabetes jab could replace daily injections
Hundreds of thousands of people with type 2 diabetes could get access to a new weekly insulin jab to replace daily injections.
August 20, 2026 at 12:39 AMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMNovo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PMNovo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMObesity rates have doubled in England since 1993 - what's going on?
Around seven million more adults are living with obesity than would have been if obesity rates had stayed the same as 1993.
August 7, 2026 at 06:38 PM